Combined inhibition of β-catenin and Bcr–Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo

H. Zhou, P. Y. Mak, H. Mu, D. H. Mak, Z. Zeng, J. Cortes, Q. Liu, M. Andreeff, B. Z. Carter

Research output: Contribution to journal › Article › peer-review

75 Scopus citations

Fingerprint

Dive into the research topics of 'Combined inhibition of β-catenin and Bcr–Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences